Loading clinical trials...
Loading clinical trials...
Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)
Conditions
Interventions
Longeveron Mesenchymal Stem Cells
Locations
5
United States
Emory University/Childen's Healthcare of Atlanta
Atlanta, Georgia, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
Johns Hopkins University Hospital
Baltimore, Maryland, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
University of Utah/Heart Center-Primary Children's Hospital
Salt Lake City, Utah, United States
Start Date
February 21, 2018
Primary Completion Date
June 30, 2024
Completion Date
December 31, 2025
Last Updated
October 4, 2023
Lead Sponsor
Longeveron Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions